By Counterforce Health Team in Xenpozyme (olipudase alfa-rpcp) —

Do You Qualify for Xenpozyme Coverage by UnitedHealthcare in New York? Decision Tree & Next Steps

Answer Box: Your Fastest Path to Xenpozyme Coverage

Yes, you likely qualify for Xenpozyme (olipudase alfa-rpcp) coverage by UnitedHealthcare in New York if you have confirmed ASMD (Niemann-Pick disease types A/B) with enzyme deficiency <10% and genetic testing showing biallelic SMPD1 mutations. The fastest path: (1) Gather enzyme assay and genetic test results, (2) Submit prior authorization through the UnitedHealthcare Provider Portal with complete clinical documentation, (3) If denied, file an external appeal with New York State Department of Financial Services within 4 months. Start today by verifying your plan's specialty pharmacy requirements through OptumRx.

Table of Contents

  1. How to Use This Decision Tree
  2. Eligibility Triage: Do You Qualify?
  3. If "Likely Eligible": Your Action Plan
  4. If "Possibly Eligible": Tests You Need
  5. If "Not Yet": Alternative Strategies
  6. If Denied: New York Appeal Options
  7. Visual Flowchart & Quick Reference
  8. Resources & Verification

How to Use This Decision Tree

This guide helps patients and clinicians navigate UnitedHealthcare's prior authorization process for Xenpozyme in New York. Work through each section sequentially—the eligibility triage determines your pathway, and each outcome has specific next steps.

Note: UnitedHealthcare requires prior authorization for Xenpozyme through OptumRx, with decisions typically within 72 hours of complete submission.

Eligibility Triage: Do You Qualify?

Coverage at a Glance

Requirement What It Means Where to Find It Source
PA Required Prior authorization mandatory OptumRx specialty drug list UnitedHealthcare PA Requirements
Diagnosis Confirmed ASMD (Niemann-Pick A/B) Enzyme assay + genetic testing ASMD Diagnostic Guidelines
Specialist Oversight Metabolic or genetic specialist Provider credentials/consultation OptumRx PA Form
Site of Care Approved infusion center Network directory UnitedHealthcare Provider Portal
Appeals Deadline 180 days internal, 4 months external Denial letter NY DFS External Appeals

Quick Eligibility Check

Answer YES or NO to each question:

  1. Confirmed ASMD diagnosis? Do you have enzyme assay results showing <10% acid sphingomyelinase activity AND genetic testing confirming biallelic SMPD1 mutations?
  2. Organ involvement documented? Do you have evidence of spleen enlargement, lung disease, liver involvement, or blood count abnormalities?
  3. Specialist involvement? Is a metabolic specialist, geneticist, or hematologist prescribing or consulting on your care?
  4. No CNS manifestations? Xenpozyme is NOT approved for central nervous system symptoms (severe neurologic Niemann-Pick type A).

Results:

  • 4 YES answers = Likely Eligible → Proceed to Action Plan
  • 2-3 YES answers = Possibly Eligible → Complete missing requirements first
  • 0-1 YES answers = Not Yet → Consider alternative approaches

If "Likely Eligible": Your Action Plan

Step-by-Step: Fastest Path to Approval

  1. Verify Plan Benefits (Patient/Clinic Staff)
    • Call UnitedHealthcare member services (number on ID card)
    • Confirm OptumRx specialty pharmacy coverage
    • Document: Prior authorization required, formulary tier, copay/coinsurance
    • Timeline: Same day
  2. Gather Required Documentation (Clinic)
    • Enzyme assay results (<10% ASM activity)
    • Genetic testing (biallelic SMPD1 mutations)
    • Baseline organ measurements (spleen size, platelet count, lung function)
    • Clinical notes documenting ASMD symptoms and impact
    • Timeline: 1-2 weeks if tests completed
  3. Complete Prior Authorization (Prescriber)
    • Submit via UnitedHealthcare Provider Portal or OptumRx ePA
    • Include medical necessity letter (see Clinician Corner below)
    • Fax backup: 1-866-434-5523
    • Timeline: 72 hours for decision
  4. Select Specialty Pharmacy (Patient/Clinic)
    • Use OptumRx network or approved alternative
    • Coordinate with infusion center for administration
    • Timeline: 1-2 business days
  5. Schedule Infusion (Patient)
    • Must be at approved outpatient infusion center
    • Verify site is UnitedHealthcare in-network
    • Timeline: Based on center availability

Clinician Corner: Medical Necessity Letter Checklist

Essential Elements:

  • Diagnosis confirmation: "Patient has confirmed ASMD with enzyme assay showing [X]% ASM activity (reference range) and genetic testing revealing [specific mutations]"
  • Clinical rationale: Document organ involvement, functional impact, and treatment goals
  • FDA approval reference: "Xenpozyme is the only FDA-approved enzyme replacement therapy for ASMD"
  • Monitoring plan: Include baseline measurements and follow-up schedule
  • Specialist credentials: Board certification in relevant specialty

Guidelines to cite:

If "Possibly Eligible": Tests You Need

Missing Diagnosis Confirmation

If enzyme testing incomplete:

  • Order acid sphingomyelinase activity assay in leukocytes
  • Use accredited laboratory (ISO 15189 certified preferred for insurance)
  • Expected result: <10% of normal activity confirms biochemical diagnosis
  • Timeline: 2-3 weeks for results

If genetic testing needed:

  • Order SMPD1 gene sequencing after low enzyme activity confirmed
  • Document family history and clinical presentation in test requisition
  • Insurance typically covers genetic testing after enzyme deficiency proven
  • Timeline: 3-4 weeks for results

If specialist consultation missing:

  • Refer to metabolic specialist, medical geneticist, or hematologist
  • Document consultation notes and treatment recommendations
  • May expedite prior authorization review
  • Timeline: 2-6 weeks for appointment

Tracking Your Progress

Reapply when you have:

  • Both enzyme and genetic confirmation
  • Specialist evaluation and recommendations
  • Baseline organ function measurements
  • Updated clinical documentation of disease impact

If "Not Yet": Alternative Strategies

Exception Request Strategy

Even without complete eligibility, you may request coverage based on:

Medical urgency: Rapidly progressive organ involvement or complications

  • Document declining organ function with serial measurements
  • Specialist letter emphasizing urgency and lack of alternatives
  • Request expedited review (72-hour decision)

Lack of alternatives: No other FDA-approved treatments for ASMD

  • Emphasize Xenpozyme is the only specific therapy
  • Document supportive care limitations
  • Reference orphan drug designation and unmet medical need

Preparing for Future Application

Build your case:

  • Complete diagnostic workup systematically
  • Document disease progression over time
  • Establish specialist relationship early
  • Consider participation in patient registry or natural history studies

Financial assistance options:

If Denied: New York Appeal Options

Appeal Path Chooser

Internal Appeals (Required First Step):

  • Deadline: 180 days from denial date
  • Submit via UnitedHealthcare Provider Portal or mail/fax
  • Include additional clinical documentation and specialist letters
  • Timeline: Standard review within 30 days, expedited within 72 hours

External Appeal Through New York DFS:

  • Deadline: 4 months after final internal denial
  • File online at NY DFS External Appeal Portal
  • Fee: $25 maximum (waived for Medicaid/financial hardship)
  • Decision is binding on UnitedHealthcare
  • Timeline: 30 days standard, 72 hours expedited

Common Denial Reasons & Fixes

Denial Reason How to Overturn Documents Needed
Insufficient diagnostic evidence Submit complete enzyme and genetic testing Lab reports, genetic counselor summary
Not medically necessary Provide detailed clinical justification Medical necessity letter, symptom documentation
Site of care restriction Confirm approved infusion center Network verification, site authorization
Experimental/investigational Cite FDA approval and clinical guidelines FDA label, treatment guidelines

New York-Specific Appeal Advantages

Strong consumer protections:

Free assistance available:

  • Community Health Advocates helpline: 1-888-614-5400
  • New York State Department of Financial Services consumer assistance
  • Legal aid organizations for complex cases

Visual Flowchart & Quick Reference

Decision Tree Summary

Start → Confirmed ASMD Diagnosis?
├─ YES → Specialist Involved?
│  ├─ YES → Submit PA → Approved? → Start Treatment
│  │                    └─ NO → Internal Appeal → External Appeal
│  └─ NO → Get Specialist Consultation → Submit PA
└─ NO → Complete Diagnostic Testing → Return to Start

Key Contacts & Forms

UnitedHealthcare:

  • Provider Portal: uhcprovider.com
  • Member Services: Number on insurance card
  • OptumRx PA Fax: 1-866-434-5523

New York Appeals:

Resources & Verification

Navigating insurance coverage for rare disease treatments can be complex, but New York residents have strong appeal rights and support resources. Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters and plan policies to craft point-by-point rebuttals aligned with payer requirements.

Official Sources for Current Information

Frequently Asked Questions

How long does UnitedHealthcare prior authorization take in New York? Standard review is completed within 72 hours of receiving complete documentation. Expedited review for urgent medical needs may be faster.

What if Xenpozyme is non-formulary on my plan? Non-formulary drugs can still be covered through medical exception requests. Document medical necessity and lack of formulary alternatives.

Can I request an expedited appeal in New York? Yes, if your physician attests that standard review timelines would seriously jeopardize your health. Expedited external appeals through NY DFS are decided within 72 hours.

Does step therapy apply if I've tried treatments outside New York? Documentation of prior therapy failures from any location should be accepted. Include complete medical records and specialist notes.

What counts as medical necessity for Xenpozyme? Confirmed ASMD diagnosis with documented organ involvement, functional impairment, and specialist recommendation. Reference UnitedHealthcare medical policies for current criteria.

From Our Advocates

We've seen patients successfully overturn Xenpozyme denials by submitting comprehensive diagnostic documentation upfront and leveraging New York's external appeal process when needed. The key is ensuring both enzyme and genetic testing results are clearly presented, along with specialist attestation of medical necessity. While outcomes vary, thorough preparation significantly improves approval chances.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Coverage decisions depend on individual plan benefits and clinical circumstances. Always consult with your healthcare provider and insurance plan for personalized guidance. For official appeals assistance in New York, contact the Department of Financial Services or Community Health Advocates.

The Counterforce Health platform helps patients and clinicians navigate complex prior authorization requirements by analyzing plan policies and crafting targeted appeals with appropriate clinical evidence and regulatory citations.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.